Clinical Trials on Relapsed in China

Total 3773 results

Tang-Du Hospital

Unknown

PET/MRI Study on the Neurological Mechanism of rTMS Treatment for Heroin Addiction

Relapse | Heroin Addiction

China
Peking Union Medical College Hospital

Unknown

Circulating Plasmablast in Diagnosis and Relapse Prediction of IgG4-RD

Plasmablast/Plasma Cells in Diagnosis of IgG4-RD | Plasmablast/Plasma Cells in Relapse Prediction of IgG4-RD

China
Guangzhou Psychiatric Hospital

Completed

A Study of Repetitive Transcranial Magnetic Stimulation in Bipolar Patients

Cognitive Impairment | Bipolar Disorder | Relapse

China
Second Affiliated Hospital of Xi'an Jiaotong University
Nanjing Legend Biotech Co.

Terminated

Study Evaluating Safety and Efficacy of CAR-T Cells Targeting CD123 in Patients With Acute Leukemia

Acute Myeloid Leukemia | Acute Leukemia | Acute Leukemia in Relapse | Relapsed or Refractory Acute Leukemia

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease

Graves Disease | Treatment | Relapse | Drug Withdrawal

China
Peking University People's Hospital

Unknown

Combination of Danazole With Berberine in the Treatment of ITP

Corticosteroid-resistant or Relapsed ITP

China
The First Hospital of Jilin University

Active, not recruiting

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Relapsed Adult AML | Relapsed Adult ALL

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Single Arm Clinical Study on the Safety and Efficacy of Personalized KSX01-TCRT in Patients With Advanced Solid Tumors

Refractory Solid Tumors | Relapsed Solid Tumors

China
Xinxiang medical university

Recruiting

NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors

Relapsed/Refractory Solid Tumors

China
Minghui Pharmaceutical (Shanghai) LTD

Recruiting

This is a Phase 1 Study of MH048 in Patients With Selected Relapsed/Refractory B-cell Malignancies

Relapsed/Refractory B-cell Malignancies

China
Apollomics Inc.
Zhejiang CrownMab Biotech Co. Ltd

Recruiting

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Relapsed/Refractory AML

China
Fujian Medical University

Unknown

CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)

Relapsed/Refractory AML

China
Zhejiang University
Yake Biotechnology Ltd.

Recruiting

CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies

Acute Lymphoblastic Leukemia, in Relapse | Multiple Myeloma in Relapse | Multiple Myeloma, Refractory | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Acute Lymphocytic Leukaemia Refractory

China
Apollomics Inc.
Zhejiang CrownMab Biotech Co. Ltd

Recruiting

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Relapsed/Refractory AML

China
The Affiliated Hospital of the Chinese Academy...
Chinese PLA General Hospital

Unknown

Allogeneic CART-33 for Relapsed/Refractory CD33+ AML

Relapsed and/or Refractory CD33+ AML

China
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Anhui Provincial Hospital

Not yet recruiting

UTAA09 Injection in the Treatment of Relapsed/Refractory Hematolymphatic Malignancies.

CD19-positive Relapsed or Refractory B-cell Malignancies

China
EdiGene (GuangZhou) Inc.
The First Affiliated Hospital of Henan University of Science and Technology

Active, not recruiting

A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)

Relapsed or Refractory B-cell Malignancy(NHL/ALL)

China
huishengai

Completed

Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation

Relapse Leukemia

China
Aibin Liang，MD，Ph.D.
CARsgen Therapeutics Co., Ltd.

Recruiting

Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

Relapsed and/or Refractory Multiple Myeloma | Plasma Cell Leukemia in Relapse

China
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

CLL-1 CAR-NK Cells for Relapsed/Refractory AML

Relapsed Adult AML | Refractory AML

China
Ruijin Hospital
National Natural Science Foundation of China; Shanghai Mental Health Center; Suzhou... and other collaborators

Unknown

The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention

Opiate Addiction

China
Shanghai Children's Medical Center
Chinese University of Hong Kong; Nanfang Hospital of Southern Medical University and other collaborators

Recruiting

TCDαβ/CD45RA Haploidentical Transplantation in Children With Leukemia

Relapsed Pediatric AML | Relapsed Pediatric ALL | Acute Graft-Versus-Host Disease (Gvhd) Grade IV (Diagnosis)

China
Shanghai Mental Health Center

Unknown

Effect Study of Optimized Intervention to Heroin Addicts

Heroin Dependence

China
Shanghai Jiao Tong University School of Medicine

Completed

Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

Relapse Rate After Allo-HSCT

China
Peking Union Medical College Hospital

Recruiting

A Prospective Cohort Study of IgG4RD in China

IgG4-related Disease

China
The First Affiliated Hospital of Soochow University

Not yet recruiting

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

Relapsed/Refractory AML

China
National Institute on Drug Dependence, China

Completed

Effect of Stress on Heroin-Related Memory Retrieval

Heroin Dependence | Learning and Memory

China
Peking University

Recruiting

UTAA06 Injection for Treatment of Advanced Malignant Solid Tumors

Conditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid Tumor

China
Changhai Hospital

Recruiting

Tofatib Treatment for IgG4-related Disease

IgG4-related Disease

China
Peking Union Medical College Hospital

Recruiting

National Registry of IgG4-RD in China

IgG4-Related Disease

China
Shanghai Mental Health Center

Completed

The Application of Music Therapy in Female Amphetamine Use Disorder

Amphetamine Addiction

China
Hrain Biotechnology Co., Ltd.
Shanghai Changzheng Hospital

Active, not recruiting

Anti-CD19/BCMA Bispecific CAR-T Cell Therapy for R/R POMES

POMES Syndrome | Relapsed and Refractory POMES Syndrome

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Unknown

Clinical Trial of Mitoxantrone HCL Liposome Injection in Patients With Relapsed DLBCL and PT/NKCLs

Relapsed DLBCL and PT/NKCLs

China
Chinese PLA General Hospital

Recruiting

CAR-T-19 Cells for Patients With CD19+ Relapse/Refractory B-ALL

CD19+ Relapse/Refractory B-ALL

China
Peking University People's Hospital

Recruiting

Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia

Refractory Leukemia | Stem Cell Transplant Complications | Relapse Leukemia

China
Beijing Pins Medical Co., Ltd
Beijing Tiantan Hospital

Unknown

PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction

Opioid Addiction

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Recruiting

A Study of TQ-B3525 on Tolerance and Pharmacokinetics

Relapsed or Refractory Lymphoma or Advanced Cancer

China
Shanghai Mental Health Center

Completed

The Diagnostic Assessment and Intervention Study of Amphetamine Type Stimulus

Amphetamine Addiction

China
Shanghai Mental Health Center

Recruiting

Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD

Amphetamine-Related Disorders

China
Shanghai Mental Health Center

Recruiting

Robot-Assisted Intelligent Rehabilitation Treatment for Methamphetamine Use Disorders.

Amphetamine Addiction

China
Shanghai Mental Health Center

Not yet recruiting

Closed-loop tACS Modulation for the Core Clinical Features of Drug Addiction

Amphetamine Use Disorders

China
Chengdu University of Traditional Chinese Medicine

Recruiting

EA for Protracted Withdrawal of OUD

Opioid-Related Disorders

China
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Efficacy of Repetitive Transcranial Magnetic Stimulation and Cognitive Behavioral Therapy on Heroin Dependence (THED)

Heroin Dependence

China
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Ovarian Cancer Patients

Relapsed Ovarian Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Intense Monitoring Study on Tyvyt

Relapsed or Refractory Classical Hodgkin's Lymphoma

China
First Affiliated Hospital of Chongqing Medical...

Enrolling by invitation

Efficacy and Safety of Intravitreal Conbercept With Modified Treat-and-Extend Regimens in Exudative AMD (IIT-A)

Exudative Age-Related Macular Degeneration

China
Huabo Biopharm Co., Ltd.

Completed

A Study of Single Intravitreal Injection HB002.1M in Subjects With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration

China
Beijing Boren Hospital

Terminated

A Study of OVV-01 Injection in Combination With IBR900 Cell Injection in Patients With Advanced Malignant Tumors

Advanced Solid Tumor | Relapsed/Refractory Lymphoma

China
Yale University
National Institute on Drug Abuse (NIDA); Centers for Disease Control and Prevention...

Completed

Behavioral Drug and HIV Risk Reduction Counseling With MMT in China

Opiate Dependence

China
Peking University People's Hospital

Recruiting

Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT

Leukemia, Myeloid, Acute | Stem Cell Transplant Complications | Leukemia Relapse

China

Clinical Trials on Relapsed in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations